| Dir : /home/ithome/mail/cur/ |
| Server: Linux host100322.itwesthosting.com 3.10.0-1160.144.1.el7.tuxcare.els4.x86_64 #1 SMP Tue Apr 7 08:40:40 UTC 2026 x86_64 IP: 144.91.64.173 |
| Dir : /home/ithome/mail/cur/1757315046.M25058P8926.host100322.itwesthosting.com,S=40386,W=41251:2, |
Return-Path: <bounces+276406-8c7c-marija.kopfer=bolnica-lipik.hr@em4602.pharmiweb.com>
Delivered-To: ithome@host100322.itwesthosting.com
Received: from host100322.itwesthosting.com
by host100322.itwesthosting.com with LMTP
id 6LdZAeZ/vmjeIgAAp0YrwQ
(envelope-from <bounces+276406-8c7c-marija.kopfer=bolnica-lipik.hr@em4602.pharmiweb.com>)
for <ithome@host100322.itwesthosting.com>; Mon, 08 Sep 2025 09:04:06 +0200
Return-path: <bounces+276406-8c7c-marija.kopfer=bolnica-lipik.hr@em4602.pharmiweb.com>
Envelope-to: marija.kopfer@bolnica-lipik.hr
Delivery-date: Mon, 08 Sep 2025 09:04:06 +0200
Received: from o1.emails.pharmiweb.com ([50.31.54.149]:64104)
by host100322.itwesthosting.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256
(Exim 4.96.2)
(envelope-from <bounces+276406-8c7c-marija.kopfer=bolnica-lipik.hr@em4602.pharmiweb.com>)
id 1uvVv1-0002TJ-10
for marija.kopfer@bolnica-lipik.hr;
Mon, 08 Sep 2025 09:04:05 +0200
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=pharmiweb.com;
h=content-type:date:from:mime-version:subject:reply-to:to:
list-unsubscribe:list-unsubscribe-post:cc:content-type:date:from:subject:to;
s=s1; bh=2B9g97D4F2qXja3HLFVVQnwoj6vUkKmkow2p+k0ccwA=;
b=n9sUIkhfS3loYyyN14xlCEgEGCuLzEl70uD57khJQDqwq1y5uS7RrIPAMgBmghf1XCox
jzkB/4ICVJpFEYZ2pUYT/6tb+EZ8/LZUkNkx5MmSv5LsIk4e04g2eARurZnZSKP92b63/l
z7ymscnAPRo7KQ3ZPhFbl+fgQ/YQzZpC3BXJVA20dTTHzMSlE744TZL/LzhbYJFS3EhzpL
xuYNzdNdY0xTrvn1NUxJmVxZizmUkEwJbCWo8s70kUBmKTUxMZ9FXBoTV9wpIKvakSujUl
y92wsjUwX2PIpus9jrY2QaY1DUN1gxiXW+FZOuE8eTNPjNZf4cIKvvoWrBYGpqfg==
Content-Type: multipart/alternative; boundary=63ae01bf88ffec28969c1c39542d6f9ff739600fc1143452e48838919bda
Date: Mon, 08 Sep 2025 07:04:01 +0000 (UTC)
From: PharmiWeb Editor <editor@pharmiweb.com>
Mime-Version: 1.0
Subject: Worldwide Clinical Trials | Employee Spotlight: Satish Kumar,
Senior Manager, Process Improvement, Early Phase
Message-ID: <fepUzNZMQ-aInSfa6btXhg@geopod-ismtpd-9>
Reply-To: editor@pharmiweb.com
X-SG-EID:
=?us-ascii?Q?u001=2EhKTSNrahB8GW1Wh+olFKwenpjZex1x7aLbO5GM6z9yOL1KiLtwGXfpycL?=
=?us-ascii?Q?H10t8u7sTFN3EwPnN6ZLvFY59MRORB8b9UWWuw5?=
=?us-ascii?Q?m7E=2FitZmXFgC59e9jVFYGf4jyYtJouJSQm0HdSp?=
=?us-ascii?Q?yc9OhM85mCWN7uoGBMg1Ka2nH8s4noXw+2BWSdB?=
=?us-ascii?Q?9KQ+hd0ljpPL8nRvKhgoWOLJzfMcQnNZ2Jur8x0?=
=?us-ascii?Q?TwKt1x+zMNcNfogVPXx4DP=2F3BCv7hjEPvgFIMNj?=
=?us-ascii?Q?6AqqEMMxFrtuBZjWa=2Fnlp1GOnw=3D=3D?=
X-SG-ID:
=?us-ascii?Q?u001=2E3RPxwXHvfbZY57uFbcgx0zyERgToqxjs2PC16CDMi+hmJk+3Hay+pmtks?=
=?us-ascii?Q?h2tPNfCQlb4uX+xSpfREkO6ujUOC51OUe+3i6+M?=
=?us-ascii?Q?+oiYldxqwChFmvbqEjIVdQd+Zb8pxIa+Q9iRuit?=
=?us-ascii?Q?YoD4gRK2tw9Ykn9uWCaROZQgy5k3MUBsjZZiDGh?=
=?us-ascii?Q?NpbLcKRft0VeBA+xEzBLRM0S7LwsFXbqwh4eeeI?=
=?us-ascii?Q?NK868TMXRIVnGgvV=2FCgSQw=3D?=
To: marija.kopfer@bolnica-lipik.hr
X-Entity-ID: u001.4C5tST+3hneuy9Yd1IKI8A==
List-Unsubscribe:
=?us-ascii?Q?=3Chttps=3A=2F=2Fu276406=2Ect=2Esendgrid=2Enet=2Flu=2Funsubscribe=3Foc=3Du001=2Ef7Dp-Q?=
=?us-ascii?Q?CcpAwGZCaWZ25O-PMeihLfSrx6PeXCMqOixeRpB?=
=?us-ascii?Q?wlI5l3ZlVfcMd7t0cIx-La1ZT9W8wOnoceOu7Us?=
=?us-ascii?Q?253EhFDIYoihMGv7rKOoGyNHLN6musTK9jO-lNJ?=
=?us-ascii?Q?SHtCSqK9b5iDIxbfDYPPKMwJV=5FSXhrUR0jyMpyZ?=
=?us-ascii?Q?KeUFfh5jG6WdrVR1EC2FPXgQWmWSJT71guN22ML?=
=?us-ascii?Q?ZyjVYHI66ai0XbRzpARSj5xQwk6y8ySVR58bWty?=
=?us-ascii?Q?k5sOC1L49JUeUFSIHuzYJA-umRIKIYsJybt1mgp?=
=?us-ascii?Q?6e6yDijZp4h2Tg=5FsaV8ZXSH1XZ8cUOa0Stn1tDF?=
=?us-ascii?Q?0igyy58NM37HxQIDwe9mZ-e-024aChw9=5FG4wZmm?=
=?us-ascii?Q?kiIQ8CJpS3o-ZQ64oOsDwqgahA4LhJmDOljUAVM?=
=?us-ascii?Q?51qCJHXPJvfJ2bTv2y=5FU-d3tU=5FUdOME=5F=5FCGc295?=
=?us-ascii?Q?ltn96bRcFotV2Iam7TukNt4OPUsZ3onMgo2Cugt?=
=?us-ascii?Q?1HJlbpzw9HnIR-pLvNxy4=5FYDU6BVwn=5FWUNLoYIc?=
=?us-ascii?Q?XgNylvZwUY7t3XBmpwy8zSzXKLeqeDQ4X9ReTDS?=
=?us-ascii?Q?-uPbjAP9rx9pflTmC656uabVv5d-yqxS5mSZ5W=5F?=
=?us-ascii?Q?vvP2CVWG=5Fsi586=5FwxpDjTZi4PZh74-1afeWtFQH?=
=?us-ascii?Q?So5j1nFZk-x7aNJuWnjok4LxKO4fEZmExI3YAAP?=
=?us-ascii?Q?EJgEROWi9FyaMvP90ZFe3jULqmPOTB2NuDgHbrW?=
=?us-ascii?Q?QNcpbHXJ4-DtvM4Cp0PInwF-OHj743d3H5EDWWX?=
=?us-ascii?Q?6FTrHU80orpuzRfqOh9Q5Xht1Y1nNDSajQY=5F8qJ?=
=?us-ascii?Q?9aBDOCQ90FOgc3hQ81UgyHNfyvt8b1U7drz-ejJ?=
=?us-ascii?Q?jH=5FSBQbmubd2oVjhQtGWTcd8Jvf-ak0RO2dXcM-?=
=?us-ascii?Q?UlkYwYFDni0hhn3SbqDXNlvIdz6pplRFy4kRTYj?=
=?us-ascii?Q?DpbzsiYhOSFMbz9x=5FrW5vE96pn3WuvBQpVVuf0N?=
=?us-ascii?Q?WUj2jKHAIVYg9EAsfV=3E=2C=3Cmailto=3Aunsubscribe?=
=?us-ascii?Q?=40em4602=2Epharmiweb=2Ecom=3Fsubject=3D276406=2ENa?=
=?us-ascii?Q?DgJC4t-vBNlL=5Fnhjba2lJxHgJ0LX4aUbs78vWeJ?=
=?us-ascii?Q?atoMDAwdTAwMAuBK1iyzQygXQXAeQ4v9AQR8Qle?=
=?us-ascii?Q?ya3ynXgOsiSATHkIUtMjhCa5DIzOKFlFClUsOX4?=
=?us-ascii?Q?rwYU3wBdqZJnatuTLHXn9c8tQ-XopbXru6IV0Cg?=
=?us-ascii?Q?6CG823tg=5FQoypvLaUNefaQXw=3D=3D=2EydtlSq4DyVNY?=
=?us-ascii?Q?3UzEwUZnIJ5e55NkGHGtB76nGMkZLWtoMDAwdTA?=
=?us-ascii?Q?wMLuyj8Ip=5FxvlnDG1qQVVMZLng-WS9w5mRlj8NX?=
=?us-ascii?Q?duWazeiA9aRvL9Y4slWuN2WzhqoQt539YciGpsd?=
=?us-ascii?Q?lsGtH7mXX1x=5Fpf0nHrh9GG9RD4UMIH720SXOC-K?=
=?us-ascii?Q?BYbNpBcESrUaGu8vcOQlL6M-tqj4CRnJL7tUDtN?=
=?us-ascii?Q?blyIOnrmp54KUGUUAVpxhoGKOHQa0I4tBddfat4?=
=?us-ascii?Q?7U6TKTP1IejgvlKLAYhlA9sZjNBI563wZ8H75SE?=
=?us-ascii?Q?9C0aNl6mVwIXjKpj3VYojKmRXbnYA0QoKuLqVzW?=
=?us-ascii?Q?WAjfeuU-kZtXNXW1al-4C=5F-AANuXVFymVY2yLYq?=
=?us-ascii?Q?4vgzFKQ3FPdIugMGovx5oFD4bKVOUAtJqcrZhJD?=
=?us-ascii?Q?h44aP6b-A6uYrTU5Nh3G-mD8H1SwPvTp6da0=5Fqh?=
=?us-ascii?Q?aUjdioE42Hw2jytW8o=3D=3E?=
List-Unsubscribe-Post: List-Unsubscribe=One-Click
X-Spam-Status: No, score=0.3
X-Spam-Score: 3
X-Spam-Bar: /
X-Ham-Report: Spam detection software, running on the system "host100322.itwesthosting.com",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Sent by PharmiWeb.jobs - Global Life Science Jobs. View it
in your browser https://sg-mktg.com/MTc1NzMxNTAzMXxHVkhLR195MndKaVBUcGtodWxKMzhVQzB3dm45a0hrU0YtUjY3bUhqM3RCRGkwQXdwMDBuWXY4VnVMX3NwVzFTMnhkR
[...]
Content analysis details: (0.3 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: cloudfront.net]
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[50.31.54.149 listed in bl.score.senderscore.com]
-0.0 SPF_PASS SPF: sender matches SPF record
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE:
The query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[50.31.54.149 listed in sa-accredit.habeas.com]
0.0 HTML_MESSAGE BODY: HTML included in message
0.5 KAM_REALLYHUGEIMGSRC RAW: Spam with image tags with ridiculously
huge http urls
0.0 _SCC_HTML_ODDDIV8 RAW: Idiosyncratic HTML structure used by
spammers
0.0 _SCC_HTML_ODDDIV8 RAW: Idiosyncratic HTML structure used by
spammers
0.0 _SCC_HTML_ODDDIV8 RAW: Idiosyncratic HTML structure used by
spammers
0.0 _SCC_HTML_ODDDIV8 RAW: Idiosyncratic HTML structure used by
spammers
0.0 _SCC_HTML_ODDDIV8 RAW: Idiosyncratic HTML structure used by
spammers
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
-0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from
envelope-from domain
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
X-Spam-Flag: NO
X-From-Rewrite: unmodified, forwarded message
--63ae01bf88ffec28969c1c39542d6f9ff739600fc1143452e48838919bda
Content-Transfer-Encoding: quoted-printable
Content-Type: text/plain; charset=utf-8
Mime-Version: 1.0
Sent by PharmiWeb.jobs - Global Life Science Jobs. View it in your browser =
https://sg-mktg.com/MTc1NzMxNTAzMXxHVkhLR195MndKaVBUcGtodWxKMzhVQzB3dm45a0h=
rU0YtUjY3bUhqM3RCRGkwQXdwMDBuWXY4VnVMX3NwVzFTMnhkR2ljUTE4OXZCWm1xU3B3Z2JDaX=
Q4Q2tqcUVLM0VPR3Z1SF9NdVdadmlXamsyckpGU0FmZG1mdW5QajZDX0VfT1puQi10NlEwS0FXN=
VNfTHJtb2RxbEcxT1JTM3JQYVVxNTUzRWFwcXF3alNvVkdEdEpFd3gya0hxRjFudGZjOFFHRGdk=
QmExcWNSNE5SY3RTSkVZN3ZhbE5oY3JHTUh4WDYxOXVXM1hxUmFKQklyOVVPaldKT204c25HMkJ=
HQ09QZ21uR1F0bUdEYm1HMXyyH9oGkmYj2PRuAk6trdzt1GtnYbyCg5dOCHkgQl4yAw=3D=3D
https://www.linkedin.com/pulse/oncology-outlook-key-takeaways-from-asco-xd9=
je/?trackingId=3Dx1QAtlXgTOegBgOo27e2Ow%3D%3D
Expanding Access and Elevating Care in Oncology Research
At ASCO 2025, the spotlight was on how innovation is reshaping oncology res=
earch and care=E2=80=94making it more accessible, personalized, and patient=
-focused. Worldwide Clinical Trials is proud to be part of this transformat=
ion, helping bring cutting-edge treatments closer to the communities that n=
eed them most.
One of the most promising developments is the growing ability to conduct cl=
inical trials with greater flexibility. Remote monitoring and lab testing a=
re reducing the burden on patients, allowing them to participate in trials =
without traveling long distances. This shift is expanding access to life-ch=
anging therapies, especially for those outside major cancer centers.
Matching patients to the right trials is also becoming more precise. By con=
sidering the unique characteristics of each patient=E2=80=99s condition, re=
searchers can better align individuals with studies that offer the most pot=
ential benefit=E2=80=94improving outcomes and accelerating progress.
Another key focus at the conference was the importance of managing toxiciti=
es in advanced therapies, particularly in cell and gene treatments. As comb=
ination therapies become more common, overlapping side effects must be iden=
tified and addressed early. Using biomarkers to guide patient selection and=
monitor responses is proving essential in ensuring safety and effectivenes=
s.
The conversation also highlighted the emotional and psychological dimension=
s of clinical research. Participation in oncology trials is often driven by=
more than just access to new treatments. Patients are motivated by trust i=
n their care teams, the hope for better outcomes, and the desire to help ot=
hers. These human elements are just as vital to the success of clinical tri=
als as the science behind them.
Worldwide Clinical Trials remains committed to advancing oncology research =
that not only pushes the boundaries of medicine but also centers on the nee=
ds and experiences of patients. The future of cancer care is not just about=
innovation=E2=80=94it=E2=80=99s about inclusion, compassion, and deliverin=
g hope where it=E2=80=99s needed most.
Hear Dr.Gary Fishbein, VP Therapeutic Area Lead, Oncology discuss how advan=
ces in AI will continue to impact Oncology research and cancer care.=C2=A0
https://www.linkedin.com/feed/update/urn:li:activity:7337893749487726592
See Our Current Vacancies https://www.pharmiweb.jobs/employer/5b1e66bd-9502=
-4837-a0cc-77f36b33b628/worldwide-clinical-trials/hub/jobs
Sent by=20
PharmiWeb.Jobs https://www.pharmiweb.jobs/?utm_source=3Dpharmiweb&utm_medi=
um=3Demail&utm_campaign=3Ddedicated&utm_term=3DEUFooterLink
- Global Life Science Jobs=20
Australia https://www.pharmiweb.jobs/au/?utm_source=3Dpharmiweb&utm_medium=
=3Demail&utm_campaign=3Ddedicated&utm_term=3DAuFooterLink,
Germany https://www.pharmiweb.jobs/de/?utm_source=3Dpharmiweb&utm_medium=
=3Demail&utm_campaign=3Ddedicated&utm_term=3DDEFooterLink=20
and=20
The United States https://www.pharmiweb.jobs/us/?utm_term=3DUSFooterLink
Sponsored by many of the global leaders within the pharma industry, PharmiW=
eb has been bringing the latest Life Science jobs & news to a global audien=
ce since 1999.
Editorial Enquiries: please contact=20
editor@pharmiWeb.com. mailto:editor@pharmiWeb.com?subject=3DPW%20Editorial%=
20Enquiry
For Job Advertising, CV search, or Newsletter campaigns please contact sale=
s@pharmiweb.com mailto:sales@pharmiweb.com?subject=3DPW%20Sales%20Enquiry o=
r call +44(0) 845 5651771
Please note: we are not responsible for content that is external to our sit=
e, submitted to us by our contributors or outside our direct control.
Click here to change preferences http://url1800.pharmiweb.com/asm/?user_id=
=3D276406&data=3DDRcx7iI0a_tINKUT6dHMkF-Y57k75rXB1rmprqRvFfxoMDAwdTAwMBe0Be=
TznMu6EFCzpQOjy7hPwITMqjXXemzf1CcLWCQlyG4SMCNs7KkVB49LzkfY_z1YnNETKZYK4JD5O=
xfi7q4-u_zRUIiTg_NV0YKOCe-o16q-s2KakZlceiSSUXZ5B2yCnwFlOygMxtgGoZ4Viat0BT6R=
Ozg8O7UdZqKNMeYwIOhaVDLttrKaGtVMybwJ_UhIieGWgvtjw-jPuyN7l1ijgPwY7Y_Lye2qco4=
cCVO3stRN___cHcE_gSMwbjkmsviQuMvGymSvBLXBCzTHDWtPJq0VUmUVxlgEWnQrYy1AgvCRU-=
xKh4lFMxxH-Q8-ogqBinVNwt1MQ9ZndaLX5RCALqFPNVaN801KEom_4dTMco2D1YTHHJqlabgf3=
gI6bm05ND2Gs2Z72mSav47eOSWYJ66SdlV2H_nNHVczHbBWS8s-RJvWOFMah0wiIsWFob3Wz8kL=
npce84fS36tdG8_OOJApXSEiaxDf_IWSrs7CM-rCW0HZV9-IboCeUgGr7r7rWi-UdivxuQPqoLy=
wwOL3gXiSktgWbL1bjX1DSS3i or unsubscribe http://url1800.pharmiweb.com/asm/u=
nsubscribe/?user_id=3D276406&data=3DgxJHDBxOjvuE9aQEGCbdZrK-y4_ZRkb5bEzftng=
gUh5oMDAwdTAwMJri5IkP9F_rouKG6d43LZSTdmEgFR-fR1EORvqIrevoig4D4UZ28Fk5ljNMCS=
X-vmAsLUcgpkqbGRa7X_x7yFa92JsmetYPILAh2cjsbEw_4HWZA62ibzOzBTG8rXgBAGnqlxjmP=
E3jEjgenPwnfDW-SiGD4DJ8d47mER2KmJdkG-p7_tqV8SDL5VCEmFSbosBWF_pyFv1wfbxGWxZo=
7kZ3VVwA-dl9OKMSKtcWYX1VU0LD_uehPjWsmDyM5VUSU_uzXFTjkbDHRcrX1gQYxBoNxvbMwYn=
c0FzzJiYCuDNiAXglrrr37Ed5t-jKprLmqqLbxnUPzUSG2MWWjMc_frQ1J1XMk6rkgp4MJgDumI=
FvFbX13lPkSEGJo1GnG2r4dw44-2tr6AnLjgSz5ozIWHk2g2bfufDekNYGQvihlocvpbKyfsrpQ=
FBI6aaT8insgt0RUGEG-EXAFBaxEQZ83KttnciJ8AECeR0IQkmBOB-MIbQ8JEp5WkiQvGM7INZ3=
tXRVdb7cerGcYQVW8grlG8BwnFP-97fcuUCkESLwNsD_KAkOK4xKCdfRp6FL7I4v7Q=3D=3D
--63ae01bf88ffec28969c1c39542d6f9ff739600fc1143452e48838919bda
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset=utf-8
Mime-Version: 1.0
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org=
/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html data-editor-version=3D"2" class=3D"sg-campaigns" xmlns=3D"http://www.=
w3.org/1999/xhtml">
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dutf-8=
" />
<meta name=3D"viewport" content=3D"width=3Ddevice-width, initial-scale=
=3D1, minimum-scale=3D1, maximum-scale=3D1" /><!--[if !mso]><!-->
<meta http-equiv=3D"X-UA-Compatible" content=3D"IE=3DEdge" /><!--<![end=
if]-->
<!--[if (gte mso 9)|(IE)]>
<xml>
<o:OfficeDocumentSettings>
<o:AllowPNG/>
<o:PixelsPerInch>96</o:PixelsPerInch>
</o:OfficeDocumentSettings>
</xml>
<![endif]-->
<!--[if (gte mso 9)|(IE)]>
<style type=3D"text/css">
body {width: 600px;margin: 0 auto;}
table {border-collapse: collapse;}
table, td {mso-table-lspace: 0pt;mso-table-rspace: 0pt;}
img {-ms-interpolation-mode: bicubic;}
</style>
<![endif]-->
<style type=3D"text/css">
body, p, div {
font-family: arial;
font-size: 14px;
}
body {
color: #63666a;
}
body a {
color: #1188E6;
text-decoration: none;
}
p { margin: 0; padding: 0; }
table.wrapper {
width:100% !important;
table-layout: fixed;
-webkit-font-smoothing: antialiased;
-webkit-text-size-adjust: 100%;
-moz-text-size-adjust: 100%;
-ms-text-size-adjust: 100%;
}
img.max-width {
max-width: 100% !important;
}
.column.of-2 {
width: 50%;
}
.column.of-3 {
width: 33.333%;
}
.column.of-4 {
width: 25%;
}
@media screen and (max-width:480px) {
.preheader .rightColumnContent,
.footer .rightColumnContent {
text-align: left !important;
}
.preheader .rightColumnContent div,
.preheader .rightColumnContent span,
.footer .rightColumnContent div,
.footer .rightColumnContent span {
text-align: left !important;
}
.preheader .rightColumnContent,
.preheader .leftColumnContent {
font-size: 80% !important;
padding: 5px 0;
}
table.wrapper-mobile {
width: 100% !important;
table-layout: fixed;
}
img.max-width {
height: auto !important;
max-width: 480px !important;
}
a.bulletproof-button {
display: block !important;
width: auto !important;
font-size: 80%;
padding-left: 0 !important;
padding-right: 0 !important;
}
.columns {
width: 100% !important;
}
.column {
display: block !important;
width: 100% !important;
padding-left: 0 !important;
padding-right: 0 !important;
margin-left: 0 !important;
margin-right: 0 !important;
}
}
</style>
<!--user entered Head Start-->
=20
<!--End Head user entered-->
</head>
<body>
<center class=3D"wrapper" data-link-color=3D"#1188E6" data-body-style=
=3D"font-size: 14px; font-family: arial; color: #63666a; background-color: =
#ffffff;">
<div class=3D"webkit">
<table cellpadding=3D"0" cellspacing=3D"0" border=3D"0" width=3D"10=
0%" class=3D"wrapper" bgcolor=3D"#ffffff">
<tr>
<td valign=3D"top" bgcolor=3D"#ffffff" width=3D"100%">
<table width=3D"100%" role=3D"content-container" class=3D"out=
er" align=3D"center" cellpadding=3D"0" cellspacing=3D"0" border=3D"0">
<tr>
<td width=3D"100%">
<table width=3D"100%" cellpadding=3D"0" cellspacing=3D"=
0" border=3D"0">
<tr>
<td>
<!--[if mso]>
<center>
<table><tr><td width=3D"600">
<![endif]-->
<table width=3D"100%" cellpadding=3D"0" cellspaci=
ng=3D"0" border=3D"0" style=3D"width: 100%; max-width:600px;" align=3D"cent=
er">
<tr>
<td role=3D"modules-container" style=3D"paddi=
ng: 0px 0px 0px 0px; color: #63666a; text-align: left;" bgcolor=3D"#ffffff"=
width=3D"100%" align=3D"left">
=20
<table class=3D"module preheader preheader-hide" role=3D"module" data-t=
ype=3D"preheader" border=3D"0" cellpadding=3D"0" cellspacing=3D"0" width=3D=
"100%"
style=3D"display: none !important; mso-hide: all; visibility: hi=
dden; opacity: 0; color: transparent; height: 0; width: 0;">
<tr>
<td role=3D"module-content">
<p></p>
</td>
</tr>
</table>
<table class=3D"module" role=3D"module" data-type=3D"code" border=3D"0" c=
ellpadding=3D"0" cellspacing=3D"0" width=3D"100%" style=3D"table-layout: fi=
xed;">
<tr>
<td height=3D"100%" valign=3D"top">
<p style=3D"background-color: #6a6a6a; font-family: Arial, Helvet=
ica, sans-serif; font-size: 11px; color: #ffffff; text-align: center; font-=
size: 11px;color:#ffffff">
Sent by PharmiWeb.jobs - Global Life Science Jobs. <a clicktracking=3Doff =
clicktracking=3D"off" href=3D"https://sg-mktg.com/MTc1NzMxNTAzMXxHVkhLR195M=
ndKaVBUcGtodWxKMzhVQzB3dm45a0hrU0YtUjY3bUhqM3RCRGkwQXdwMDBuWXY4VnVMX3NwVzFT=
MnhkR2ljUTE4OXZCWm1xU3B3Z2JDaXQ4Q2tqcUVLM0VPR3Z1SF9NdVdadmlXamsyckpGU0FmZG1=
mdW5QajZDX0VfT1puQi10NlEwS0FXNVNfTHJtb2RxbEcxT1JTM3JQYVVxNTUzRWFwcXF3alNvVk=
dEdEpFd3gya0hxRjFudGZjOFFHRGdkQmExcWNSNE5SY3RTSkVZN3ZhbE5oY3JHTUh4WDYxOXVXM=
1hxUmFKQklyOVVPaldKT204c25HMkJHQ09QZ21uR1F0bUdEYm1HMXyyH9oGkmYj2PRuAk6trdzt=
1GtnYbyCg5dOCHkgQl4yAw=3D=3D" style=3D"font-family: Arial, Helvetica, sans-=
serif; font-size: 11px; color: #ffffff;decoration:underline">View it in you=
r browser</a>
</p>
</td>
</tr>
</table>
<table class=3D"module"
role=3D"module"
data-type=3D"spacer"
border=3D"0"
cellpadding=3D"0"
cellspacing=3D"0"
width=3D"100%"
style=3D"table-layout: fixed;">
<tr>
<td style=3D"padding:0px 0px 30px 0px;"
role=3D"module-content"
bgcolor=3D"#003142">
</td>
</tr>
</table>
=20
<table class=3D"wrapper" role=3D"module" data-type=3D"image" border=3D"=
0" cellpadding=3D"0" cellspacing=3D"0" width=3D"100%" style=3D"table-layout=
: fixed;">
<tr>
<td style=3D"font-size:6px;line-height:10px;padding:0px 0px 0px 0px=
;" valign=3D"top" align=3D"center">
<a href=3D"http://url1800.pharmiweb.com/ls/click?upn=3Du001.7-2Bi=
azt-2FqekSenSCev2yeOmXa1eDLAbmqr-2FKOnw9V0eDgTHUxnevJj1ooXSy5-2BdgqEGtSwqYS=
IAZChxAGO7HnWyTtqKPvY1fghY4iyzvVQNLKc7dbjao4BZxprSVQAPPIjtGYxPUEs961RTmCt3n=
Nqbdz3s5-2B3bmiQyUaiuvskFw-3D0U9M_gwq0aiRFXipdNLRMN4aK7ST6F9tJd4ihDEKFOb-2B=
wnnyvRgp4zXT2kAYncqEH5chvFurLmkrh91rs58OKIpk2QzlJL29I0yGUC3GzYj0tHVUJhG2tBH=
cjIHhC513i3PkADpzT1WoPvxuWwhjRwIq0vN6FQM1AidK0sOrrrajPEq3YJJDKhFJT6mgon3YH5=
vE-2FDLEs0INyig9cYoKR1o48dAEbzb4xa1e8hgWhXIMjk-2BEESrxwTWBmWnP3EUvL8n4Yps4e=
HSy7cuL5NyG4P9pUXgG2nAJ9ZtyE6vj3jKXbMyo8QnIZuMNt6baJBhiMe80gdalYMQWaWUX-2BJ=
AQ76Y53QwmZyqrHhCiDHiyHBVTJUYrVbLIVe4eCEeG-2BvKAEdvHziG5tBtMKIrkHorm2AWw6IL=
hrB5r2I20kiNbCCOorEo8lSAdZ0Hyd9cHVll0zWuGWHmnjwEvvTiRtKYjSusNpPg-3D-3D"><im=
g class=3D"max-width" border=3D"0" style=3D"display:block;color:#000000;tex=
t-decoration:none;font-family:Helvetica, arial, sans-serif;font-size:16px;m=
ax-width:100% !important;width:100%;height:auto !important;" src=3D"https:/=
/d375w6nzl58bw0.cloudfront.net/uploads/d76b27f369b602a23285abd9ba37b6bdaade=
b215919456af04c2d7de445c011b.png" alt=3D"" width=3D"600"></a>
</td>
</tr>
</table>
=20
<table class=3D"module" role=3D"module" data-type=3D"text" border=3D"0"=
cellpadding=3D"0" cellspacing=3D"0" width=3D"100%" style=3D"table-layout: =
fixed;">
<tr>
<td style=3D"padding:10px 0px 10px 0px;line-height:22px;text-align:=
inherit;"
height=3D"100%"
valign=3D"top"
bgcolor=3D"">
<h2><span style=3D"color:#696969;"><strong>Expanding Access and=
Elevating Care in Oncology Research</strong></span></h2>
</td>
</tr>
</table>
=20
<table class=3D"module" role=3D"module" data-type=3D"text" border=3D"0"=
cellpadding=3D"0" cellspacing=3D"0" width=3D"100%" style=3D"table-layout: =
fixed;">
<tr>
<td style=3D"padding:10px 0px 10px 0px;line-height:22px;text-align:=
justify;"
height=3D"100%"
valign=3D"top"
bgcolor=3D"">
<div>At ASCO 2025, the spotlight was on how innovation is resha=
ping oncology research and care=E2=80=94making it more accessible, personal=
ized, and patient-focused. Worldwide Clinical Trials is proud to be part of=
this transformation, helping bring cutting-edge treatments closer to the c=
ommunities that need them most.</div>
<div> </div>
<div>One of the most promising developments is the growing ability to condu=
ct clinical trials with greater flexibility. Remote monitoring and lab test=
ing are reducing the burden on patients, allowing them to participate in tr=
ials without traveling long distances. This shift is expanding access to li=
fe-changing therapies, especially for those outside major cancer centers.</=
div>
<div> </div>
<div>Matching patients to the right trials is also becoming more precise. B=
y considering the unique characteristics of each patient=E2=80=99s conditio=
n, researchers can better align individuals with studies that offer the mos=
t potential benefit=E2=80=94improving outcomes and accelerating progress.</=
div>
<div> </div>
<div>Another key focus at the conference was the importance of managing tox=
icities in advanced therapies, particularly in cell and gene treatments. As=
combination therapies become more common, overlapping side effects must be=
identified and addressed early. Using biomarkers to guide patient selectio=
n and monitor responses is proving essential in ensuring safety and effecti=
veness.</div>
<div> </div>
<div>The conversation also highlighted the emotional and psychological dime=
nsions of clinical research. Participation in oncology trials is often driv=
en by more than just access to new treatments. Patients are motivated by tr=
ust in their care teams, the hope for better outcomes, and the desire to he=
lp others. These human elements are just as vital to the success of clinica=
l trials as the science behind them.</div>
<div> </div>
<div>Worldwide Clinical Trials remains committed to advancing oncology rese=
arch that not only pushes the boundaries of medicine but also centers on th=
e needs and experiences of patients. The future of cancer care is not just =
about innovation=E2=80=94it=E2=80=99s about inclusion, compassion, and deli=
vering hope where it=E2=80=99s needed most.</div>
<p> </p>
</td>
</tr>
</table>
=20
<table class=3D"module"
role=3D"module"
data-type=3D"spacer"
border=3D"0"
cellpadding=3D"0"
cellspacing=3D"0"
width=3D"100%"
style=3D"table-layout: fixed;">
<tr>
<td style=3D"padding:0px 0px 10px 0px;"
role=3D"module-content"
bgcolor=3D"#003142">
</td>
</tr>
</table>
=20
<table class=3D"module" role=3D"module" data-type=3D"text" border=3D"0"=
cellpadding=3D"0" cellspacing=3D"0" width=3D"100%" style=3D"table-layout: =
fixed;">
<tr>
<td style=3D"padding:18px 0px 18px 0px;line-height:22px;text-align:=
inherit;"
height=3D"100%"
valign=3D"top"
bgcolor=3D"">
<div>Hear <strong>Dr.Gary Fishbein</strong>, VP Therapeutic Are=
a Lead, Oncology discuss how advances in AI will continue to impact Oncolog=
y research and cancer care. </div>
</td>
</tr>
</table>
=20
<table class=3D"wrapper" role=3D"module" data-type=3D"image" border=3D"=
0" cellpadding=3D"0" cellspacing=3D"0" width=3D"100%" style=3D"table-layout=
: fixed;">
<tr>
<td style=3D"font-size:6px;line-height:10px;padding:0px 0px 0px 0px=
;" valign=3D"top" align=3D"center">
<a href=3D"http://url1800.pharmiweb.com/ls/click?upn=3Du001.7-2Bi=
azt-2FqekSenSCev2yeOmXa1eDLAbmqr-2FKOnw9V0eDnvMqjfdKjg06vO44HClmI6T8DmXssqC=
tIFDTZp0H5vd2lM6g3j-2B6u-2FtK0qV-2F0SO4-3DO2LP_gwq0aiRFXipdNLRMN4aK7ST6F9tJ=
d4ihDEKFOb-2BwnnyvRgp4zXT2kAYncqEH5chvFurLmkrh91rs58OKIpk2QzlJL29I0yGUC3GzY=
j0tHVUJhG2tBHcjIHhC513i3PkADpzT1WoPvxuWwhjRwIq0vN6FQM1AidK0sOrrrajPEq3YJJDK=
hFJT6mgon3YH5vE-2FDLEs0INyig9cYoKR1o48dAEbzb4xa1e8hgWhXIMjk-2BEESrxwTWBmWnP=
3EUvL8n4Yfrmpei3qHWVhP9X-2FsqamWGIjdqVg1u7H8ATekeDOrnCrwVQrLJ0uY2BvgravFY30=
Eyp1DZniKusZfZrifPerlwnkb6-2FW5JZhf3EMRb5nYUbQYOlSs-2BqKm6cEgHs-2BMbhEHWp9o=
7ZbDciCesnuBW8nVjjft1mNdNBV0hURP8YfL5gQDh774lhGd4IiI-2FmgtY6Vu8KuUyumc-2Bxu=
B43hCMI0CA-3D-3D"><img class=3D"max-width" border=3D"0" style=3D"display:bl=
ock;color:#000000;text-decoration:none;font-family:Helvetica, arial, sans-s=
erif;font-size:16px;max-width:50% !important;width:50%;height:auto !importa=
nt;" src=3D"https://d375w6nzl58bw0.cloudfront.net/uploads/926ce6674e456f1fa=
0dd3004b279f32acb4f6e7d94738629fb8358b71dd8bb5b.png" alt=3D"" width=3D"300"=
></a>
</td>
</tr>
</table>
=20
<table class=3D"module"
role=3D"module"
data-type=3D"spacer"
border=3D"0"
cellpadding=3D"0"
cellspacing=3D"0"
width=3D"100%"
style=3D"table-layout: fixed;">
<tr>
<td style=3D"padding:0px 0px 10px 0px;"
role=3D"module-content"
bgcolor=3D"">
</td>
</tr>
</table>
=20
<table class=3D"module"
role=3D"module"
data-type=3D"spacer"
border=3D"0"
cellpadding=3D"0"
cellspacing=3D"0"
width=3D"100%"
style=3D"table-layout: fixed;">
<tr>
<td style=3D"padding:0px 0px 10px 0px;"
role=3D"module-content"
bgcolor=3D"#003142">
</td>
</tr>
</table>
=20
<table class=3D"module"
role=3D"module"
data-type=3D"spacer"
border=3D"0"
cellpadding=3D"0"
cellspacing=3D"0"
width=3D"100%"
style=3D"table-layout: fixed;">
<tr>
<td style=3D"padding:0px 0px 15px 0px;"
role=3D"module-content"
bgcolor=3D"">
</td>
</tr>
</table>
<table border=3D"0" cellPadding=3D"0" cellSpacing=3D"0" class=3D"module" =
data-role=3D"module-button" data-type=3D"button" role=3D"module" style=3D"t=
able-layout:fixed" width=3D"100%"><tbody><tr><td align=3D"center" class=3D"=
outer-td" style=3D"padding:0px 0px 0px 0px"><table border=3D"0" cellPadding=
=3D"0" cellSpacing=3D"0" class=3D"button-css__deep-table___2OZyb wrapper-mo=
bile" style=3D"text-align:center"><tbody><tr><td align=3D"center" bgcolor=
=3D"#139bb9" class=3D"inner-td" style=3D"border-radius:6px;font-size:16px;t=
ext-align:center;background-color:inherit"><a style=3D"background-color:#13=
9bb9;border:1px solid #333333;border-color:#139bb9;border-radius:6px;border=
-width:1px;color:#ffffff;display:inline-block;font-family:arial,helvetica,s=
ans-serif;font-size:16px;font-weight:normal;letter-spacing:0px;line-height:=
16px;padding:12px 18px 12px 18px;text-align:center;text-decoration:none" hr=
ef=3D"http://url1800.pharmiweb.com/ls/click?upn=3Du001.7-2Biazt-2FqekSenSCe=
v2yeOj3O6NlVn9yuyshKz4SaUngNIn3J2T-2BV9Dn0Ey12WD40SArNhnNtAwMBfqkhJQd8ny4gk=
npVSt8c9MWQZ7L1P5OavYH2gpPhE-2FMMKudk1A-2BcCRczJVGQwq0lCoIbIOg9c6rQqeq6ZLCl=
qtgxfkkke0k-3DeG_S_gwq0aiRFXipdNLRMN4aK7ST6F9tJd4ihDEKFOb-2BwnnyvRgp4zXT2kA=
YncqEH5chvFurLmkrh91rs58OKIpk2QzlJL29I0yGUC3GzYj0tHVUJhG2tBHcjIHhC513i3PkAD=
pzT1WoPvxuWwhjRwIq0vN6FQM1AidK0sOrrrajPEq3YJJDKhFJT6mgon3YH5vE-2FDLEs0INyig=
9cYoKR1o48dAEbzb4xa1e8hgWhXIMjk-2BEESrxwTWBmWnP3EUvL8n4Y81QTaoLvT6r94ulXcFV=
LRXHR0jaL0xZMeItxiBUuFjnhSi3uaHZxPEfrIHJQscCcl8Fo7rBw3dAODSNlSS7ZXIuhat88af=
lj-2FArNsxIHTVfCbxkO9u-2ByH-2BDPu1YBRGMy8xIFqzc6cJgtxgzZUnO-2FmMLKAQVrZ6MIH=
0An2gAf8bGWEDq0EZglZGAgz8kOZLxDkozvpQV-2BZuIMpVc8Ihzz9Q-3D-3D" target=3D"_b=
lank">See Our Current Vacancies</a></td></tr></tbody></table></td></tr></tb=
ody></table>
<table class=3D"module"
role=3D"module"
data-type=3D"spacer"
border=3D"0"
cellpadding=3D"0"
cellspacing=3D"0"
width=3D"100%"
style=3D"table-layout: fixed;">
<tr>
<td style=3D"padding:0px 0px 15px 0px;"
role=3D"module-content"
bgcolor=3D"">
</td>
</tr>
</table>
=20
<table class=3D"module"
role=3D"module"
data-type=3D"spacer"
border=3D"0"
cellpadding=3D"0"
cellspacing=3D"0"
width=3D"100%"
style=3D"table-layout: fixed;">
<tr>
<td style=3D"padding:0px 0px 10px 0px;"
role=3D"module-content"
bgcolor=3D"#003142">
</td>
</tr>
</table>
=20
<table class=3D"module"
role=3D"module"
data-type=3D"spacer"
border=3D"0"
cellpadding=3D"0"
cellspacing=3D"0"
width=3D"100%"
style=3D"table-layout: fixed;">
<tr>
<td style=3D"padding:0px 0px 30px 0px;"
role=3D"module-content"
bgcolor=3D"">
</td>
</tr>
</table>
<table class=3D"module" role=3D"module" data-type=3D"code" border=3D"0" c=
ellpadding=3D"0" cellspacing=3D"0" width=3D"100%" style=3D"table-layout: fi=
xed;">
<tr>
<td height=3D"100%" valign=3D"top">
<div style=3D"color:#63666a;font-family:arial;font-size:10px;text=
-align:center;">
<em>Sent by <strong>
<a href=3D"http://url1800.pharmiweb.com/ls/click?upn=3Du001.7-2Biazt-2F=
qekSenSCev2yeOj3O6NlVn9yuyshKz4SaUniep6-2BvP1CdNBgmGtXX76WGwLcDvKNLzuyr2p1U=
y-2FF9zb-2FJLRlXJvFvcHpAmC3qz5Hn51FRj4-2FaYa7gbOYDuOfnoKxY9XYG7jXjRniYft13C=
CqN6nmSxhwEKHzWuDW6LLY-3Dt4fo_gwq0aiRFXipdNLRMN4aK7ST6F9tJd4ihDEKFOb-2Bwnny=
vRgp4zXT2kAYncqEH5chvFurLmkrh91rs58OKIpk2QzlJL29I0yGUC3GzYj0tHVUJhG2tBHcjIH=
hC513i3PkADpzT1WoPvxuWwhjRwIq0vN6FQM1AidK0sOrrrajPEq3YJJDKhFJT6mgon3YH5vE-2=
FDLEs0INyig9cYoKR1o48dAEbzb4xa1e8hgWhXIMjk-2BEESrxwTWBmWnP3EUvL8n4YLCJf29Zo=
3o6waDAYNuPE8M4r9Y7YggG2xM9LC5yxcFus2Jy0loz5qJtwePdLNREgzbs7RkBuTCqJF0JDf-2=
Fa8ek5ELjYWG72YaqW3abkRAii5b6mLo-2FYKnoYcoBGhig-2FXWU5CkWfWrcmpPyutIGJwj7-2=
Fqv0s2eLdH3hE8nSvcoclvlk6vUE9e0N8XxGAI63cm-2FzWtLN4ZVoVxuIulFtJGjA-3D-3D" s=
tyle=3D"color: #5cafc5;font-size: 10px;">PharmiWeb.Jobs</a></strong>
- Global Life Science Jobs=20
<a href=3D"http://url1800.pharmiweb.com/ls/click?upn=3Du001.7-2Biazt-2=
FqekSenSCev2yeOj3O6NlVn9yuyshKz4SaUngAcy9eQLW4l74nx9FtG8-2B43YO024wS7EtRUc5=
40l4-2ByPw5Xbaj8wC5tmrHLmWPIshjgqHCoefTBKJDJB24pLgZ-2BEUpc-2BmQaajGlhzPZdUc=
kHwu7M-2FFqB3DUIhYjkeJoH8-3DNcKG_gwq0aiRFXipdNLRMN4aK7ST6F9tJd4ihDEKFOb-2Bw=
nnyvRgp4zXT2kAYncqEH5chvFurLmkrh91rs58OKIpk2QzlJL29I0yGUC3GzYj0tHVUJhG2tBHc=
jIHhC513i3PkADpzT1WoPvxuWwhjRwIq0vN6FQM1AidK0sOrrrajPEq3YJJDKhFJT6mgon3YH5v=
E-2FDLEs0INyig9cYoKR1o48dAEbzb4xa1e8hgWhXIMjk-2BEESrxwTWBmWnP3EUvL8n4YASWzj=
EFaB4NCrQ9He-2FVFG-2FjfxkvN6Sls8wItJ7d3tTngV3jxY6MCzLo9j-2BcdwwPfd9Yz49rqoC=
iT6d29fRSLX0PV2taKZ4CEBCJ0w5-2BENpUbKrvdy91XUvjU-2FR9DY-2FFBZ689-2BpDAuCcy8=
M46NKFY7aRSMu44giCTKGcLNV1E1sAmdrwqKRxgfMQ8ULiCwMq1FQZky042ql8IR1CgAAr-2Bjg=
-3D-3D" style=3D"color: #5cafc5;font-size: 10px;" target=3D"_blank"><font>A=
ustralia</font></a><font>,
<a href=3D"http://url1800.pharmiweb.com/ls/click?upn=3Du001.7-2Biazt-2=
FqekSenSCev2yeOj3O6NlVn9yuyshKz4SaUnjExUXQkCWfFctdAzxAmR8fYznAULyiuSeKumwv9=
WVlhik17wZmJ3YicJy2xbIt5PM7GQAxdVZhOrZWAgMjP41VpttQSGuul9hpOeAF35x3Z5GVaLMq=
I94ECh9enrwJzNE-3D-_7l_gwq0aiRFXipdNLRMN4aK7ST6F9tJd4ihDEKFOb-2BwnnyvRgp4zX=
T2kAYncqEH5chvFurLmkrh91rs58OKIpk2QzlJL29I0yGUC3GzYj0tHVUJhG2tBHcjIHhC513i3=
PkADpzT1WoPvxuWwhjRwIq0vN6FQM1AidK0sOrrrajPEq3YJJDKhFJT6mgon3YH5vE-2FDLEs0I=
Nyig9cYoKR1o48dAEbzb4xa1e8hgWhXIMjk-2BEESrxwTWBmWnP3EUvL8n4YyV3-2BT852HaJ8o=
KSaAyed89rIg9GFJtjnFDtMlYXPPekdc6Faos2ElUEP9DreAbUE29IDt2GWDW2iaFDJPC0O0ayC=
rBVsB-2BS2r-2BpRPzu-2FL-2BNAQe5eqyFbltPXYqoL-2FGT-2BlBSsINouzMmuOxJX-2BGNsr=
YCZXEz9xyIg1YpnZRFMwX2Jx-2BXtH-2BmbGICkiPwBN2B-2BeEz93hpPhYCubmx-2FT3CEjw-3=
D-3D" style=3D"color: #5cafc5;font-size: 10px;" target=3D"_blank">Germany</=
a>=20
and=20
<a href=3D"http://url1800.pharmiweb.com/ls/click?upn=3Du001.7-2Biazt-2=
FqekSenSCev2yeOj3O6NlVn9yuyshKz4SaUngDtJsbNaHEOfa9afVg7MPvVtcg8LbRK58aGGE-2=
BlfgY5A-3D-3D8IrV_gwq0aiRFXipdNLRMN4aK7ST6F9tJd4ihDEKFOb-2BwnnyvRgp4zXT2kAY=
ncqEH5chvFurLmkrh91rs58OKIpk2QzlJL29I0yGUC3GzYj0tHVUJhG2tBHcjIHhC513i3PkADp=
zT1WoPvxuWwhjRwIq0vN6FQM1AidK0sOrrrajPEq3YJJDKhFJT6mgon3YH5vE-2FDLEs0INyig9=
cYoKR1o48dAEbzb4xa1e8hgWhXIMjk-2BEESrxwTWBmWnP3EUvL8n4YbBJ4q-2BLvbpxjCkAZHU=
U59VSgOGxz9UQPsiFviXUjGpbPF-2FimlwjH22r0v9wlKZkhHYRdtaxzjBXI6YsthdpnU55yqQo=
6eiNG-2FI-2FZmDOrkcyBXPyrDIj10MIFzkOA86EsCUOArxc76Sjxg7VtZPbjodyXak6j72igU9=
SlwS5-2BuhUQ-2FhmqBDrJARgH-2BL1bKWz4c1d26jx2yGBMS9jAK8tw2Q-3D-3D" style=3D"=
color: #5cafc5;font-size: 10px;" target=3D"_blank">The United States</a><br=
>
Sponsored by many of the global leaders within the pharma industry, Pha=
rmiWeb has been bringing the latest Life Science jobs & news to a globa=
l audience since 1999.</font></em><font>
<br>
<br>
<strong>Editorial Enquiries:</strong> please contact <a href=3D"mailto:edit=
or@pharmiWeb.com?subject=3DPW%20Editorial%20Enquiry" style=3D"color: #5cafc=
5;font-size: 10px;">
editor@pharmiWeb.com.</a>
<br> For Job Advertising, CV search, or Newsletter campaigns please contact=
<a href=3D"mailto:sales@pharmiweb.com?subject=3DPW%20Sales%20Enquiry" styl=
e=3D"color: #5cafc5;font-size: 10px;">sales@pharmiweb.com</a> or call +44(0=
) 845 5651771
<br>
<br>
<em>Please note: we are not responsible for content that is external to our=
site, submitted to us by our contributors or outside our direct control.
</em></font></div><font>
</font><div style=3D"color:#63666a;font-family:arial;font-size:10px;text-al=
ign:center;"><font>
Click here to <a href=3D"http://url1800.pharmiweb.com/asm/?user_id=3D276406=
&data=3DDRcx7iI0a_tINKUT6dHMkF-Y57k75rXB1rmprqRvFfxoMDAwdTAwMBe0BeTznMu=
6EFCzpQOjy7hPwITMqjXXemzf1CcLWCQlyG4SMCNs7KkVB49LzkfY_z1YnNETKZYK4JD5Oxfi7q=
4-u_zRUIiTg_NV0YKOCe-o16q-s2KakZlceiSSUXZ5B2yCnwFlOygMxtgGoZ4Viat0BT6ROzg8O=
7UdZqKNMeYwIOhaVDLttrKaGtVMybwJ_UhIieGWgvtjw-jPuyN7l1ijgPwY7Y_Lye2qco4cCVO3=
stRN___cHcE_gSMwbjkmsviQuMvGymSvBLXBCzTHDWtPJq0VUmUVxlgEWnQrYy1AgvCRU-xKh4l=
FMxxH-Q8-ogqBinVNwt1MQ9ZndaLX5RCALqFPNVaN801KEom_4dTMco2D1YTHHJqlabgf3gI6bm=
05ND2Gs2Z72mSav47eOSWYJ66SdlV2H_nNHVczHbBWS8s-RJvWOFMah0wiIsWFob3Wz8kLnpce8=
4fS36tdG8_OOJApXSEiaxDf_IWSrs7CM-rCW0HZV9-IboCeUgGr7r7rWi-UdivxuQPqoLywwOL3=
gXiSktgWbL1bjX1DSS3i" style=3D"color: #5cafc5;font-size: 10px;">change pref=
erences</a> or <a href=3D"http://url1800.pharmiweb.com/asm/unsubscribe/?use=
r_id=3D276406&data=3DgxJHDBxOjvuE9aQEGCbdZrK-y4_ZRkb5bEzftnggUh5oMDAwdT=
AwMJri5IkP9F_rouKG6d43LZSTdmEgFR-fR1EORvqIrevoig4D4UZ28Fk5ljNMCSX-vmAsLUcgp=
kqbGRa7X_x7yFa92JsmetYPILAh2cjsbEw_4HWZA62ibzOzBTG8rXgBAGnqlxjmPE3jEjgenPwn=
fDW-SiGD4DJ8d47mER2KmJdkG-p7_tqV8SDL5VCEmFSbosBWF_pyFv1wfbxGWxZo7kZ3VVwA-dl=
9OKMSKtcWYX1VU0LD_uehPjWsmDyM5VUSU_uzXFTjkbDHRcrX1gQYxBoNxvbMwYnc0FzzJiYCuD=
NiAXglrrr37Ed5t-jKprLmqqLbxnUPzUSG2MWWjMc_frQ1J1XMk6rkgp4MJgDumIFvFbX13lPkS=
EGJo1GnG2r4dw44-2tr6AnLjgSz5ozIWHk2g2bfufDekNYGQvihlocvpbKyfsrpQFBI6aaT8ins=
gt0RUGEG-EXAFBaxEQZ83KttnciJ8AECeR0IQkmBOB-MIbQ8JEp5WkiQvGM7INZ3tXRVdb7cerG=
cYQVW8grlG8BwnFP-97fcuUCkESLwNsD_KAkOK4xKCdfRp6FL7I4v7Q=3D=3D" style=3D"col=
or: #5cafc5;font-size: 10px;">unsubscribe</a>
<p></p>
</font></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<!--[if mso]>
</td></tr></table>
</center>
<![endif]-->
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
</div>
</center>
<img src=3D"http://url1800.pharmiweb.com/wf/open?upn=3Du001.f5Dsp3T1nkw1Z=
TvWz2-2FCnIY-2B1D7lRJiXGXiyJTT-2BmR-2F6QZIVIxCpOfmhoAWtHke9IzFQimV2JesOpl4I=
c0Fv3HOU4uq-2BiZPA7pAbxWh3cXv8lvR7VTNY4pdrVgTsDI9v4hjCONCj-2FzEtARTM2BSvxYX=
VXNlBPF1N5sYCFb1TIeB3JZoTa9vE-2FDyZRtzi74FKIiiZLp-2Fp4MTrjxZcvjP1AJKB-2FhLr=
zC2dHgX8ZaQXl9al-2Bua6SFhyG1hjBCpr4PghkymmloHuCrSdWG7JPs9IFzEk3EZoDToKoBAir=
zfhqvj2wBTw5pSANa5Ka9P8udPHzaGPMyukaZ0FnxDcONLhP4Kyi7EqpYL63mWBRncAvmB-2F4I=
TS0D8LKAOU73Gu2Cqn5k2upVouevMzDNh5LBpJM-2BYU7wjCamKaM7DiLXkyS6tl6zvaf4ESyFB=
4VvrSUi01DLQAKW-2Bfzv60qQ-2B524Wa6aBHSLJf7Qttrp1UBCAGU-2B4-3D" alt=3D"" wid=
th=3D"1" height=3D"1" border=3D"0" style=3D"height:1px !important;width:1px=
!important;border-width:0 !important;margin-top:0 !important;margin-bottom=
:0 !important;margin-right:0 !important;margin-left:0 !important;padding-to=
p:0 !important;padding-bottom:0 !important;padding-right:0 !important;paddi=
ng-left:0 !important;"/></body>
</html>
--63ae01bf88ffec28969c1c39542d6f9ff739600fc1143452e48838919bda--